Evidence map›Paper›PMID 31726087›Full record

ArticleBrain, behavior, and immunity2020

Special Issue: Contexts and Consequences of Childhood Inflammation.

Jennifer M Loftis, Michelle L Byrne, Jeffrey Measelle

Abstract readEditorial
In one paragraph

Article in Brain, behavior, and immunity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jennifer M LoftisResearch & Development Service, VA Portland Health Care System, Portland, OR, USA; Department of Psychiatry, Oregon Health & Science University, Portland, OR, USA.
Michelle L ByrneDepartment of Psychology, University of Oregon, Eugene, OR, USA.
Jeffrey MeaselleDepartment of Psychology, University of Oregon, Eugene, OR, USA.

Funding

DRα1-MOG as a Next-Generation Immunotherapy for Methamphetamine Use DisorderR41DA047865 · NIDA · VIROGENOMICS BIODEVELOPMENT, INC. · PI HUCKANS, MARILYN, LOFTIS, JENNIFER M · 2019 to 2019
$300k
HCV and co-morbid alcohol use disorders: a translational investigation of antiviral therapy outcomes on CNS functionI01BX002061 · VA · PORTLAND VA MEDICAL CENTER · PI LOFTIS, JENNIFER M · 2014 to 2023
–
BLRD VA I01 BX002061NIDA NIH HHS R41 DA047865
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adverse Childhood ExperiencesInflammationAdolescentAnimalsChildHumansInfant

Identifiers

PMID31726087
PMCPMC7402616

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.